Opportunity Information: Apply for CDC RFA IP13 1305
Apply for CDC RFA IP13 1305
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Introducing or Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs Outside of the United States" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Mar 15, 2013 and posted on Mar 15, 2013.
- Applicants must submit their applications by May 14, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- The number of recipients for this funding is limited to 5 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Limited to entities within selected foreign governments that are responsible for national vaccine policy and/or program implementation.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC discretionary grant opportunity (Funding Opportunity Number CDC RFA IP13-1305) focuses on helping selected foreign governments introduce seasonal influenza vaccination where it is not yet part of routine public health programming, or expand and strengthen existing influenza vaccination efforts. The overall intent is practical and policy-oriented: provide funding, support, and technical assistance for activities that lead to national-level policy decisions about seasonal influenza vaccine use and then help countries move from those decisions into implementation of sustainable national influenza vaccination programs. In other words, the program is designed to help governments evaluate needs, build consensus, set policy, plan operations, and carry out early phases of influenza vaccine program rollout or expansion.
The opportunity was issued by the Centers for Disease Control and Prevention (CDC) under the CFDA number 93.283 (CDC Investigations and Technical Assistance). It uses a grant as the funding instrument and falls under the health activity category. CDC anticipated making about five awards with an estimated total funding amount of $3,000,000. The stated award ceiling was $250,000 per award, with an award floor of $0, and there was no cost-sharing or matching requirement, which typically means applicants were not required to contribute non-federal funds to be eligible or competitive under the announcement.
Eligibility was limited and specific. Applicants had to be entities within selected foreign governments that are responsible for national vaccine policy and/or program implementation. This indicates the funding was not broadly open to universities, NGOs, or private-sector organizations unless they were part of, or formally representing, the eligible government entities described in the full announcement. The eligibility language signals CDCs intent to fund organizations that can directly influence national immunization policy decisions and can operationalize influenza vaccination within the public health system, rather than supporting external partners acting independently of government.
From an activity standpoint, the announcement emphasizes two connected outcomes. First, it supports government-led work that produces concrete policy decisions on whether and how to introduce or expand seasonal influenza vaccination (for example, defining target groups, outlining recommendations, or establishing official vaccine policy). Second, it supports the practical implementation of national influenza vaccination programs once those policy choices are made. While the short description does not list specific allowable activities, the framing strongly suggests support for planning and decision-making processes (such as burden and risk assessments, economic or feasibility analyses, stakeholder coordination, drafting policy guidance, and strengthening advisory group processes) alongside implementation supports (such as program planning, logistics, training, communication approaches, monitoring, and early rollout activities). The common thread is building a functioning, government-owned seasonal influenza vaccination program rather than a one-time campaign.
Key timeline details reflect that this was a time-limited, archived opportunity. The posting date and creation date were March 15, 2013, with an original and current closing date of May 14, 2013, and an archive date of June 13, 2013. The source also notes that the additional information link provided in the listing was not active and instructed users to access the full announcement through the main posting interface. For help retrieving the full announcement, CDC directed applicants to the Procurement and Grants Office (PGO), Technical Information Management Section (TIMS), with contact options by phone (770-488-2700) and email (pgotim@cdc.gov).
In practical terms, the grant can be read as CDC support for national governments to move along the full pathway from evidence and deliberation to policy adoption and operational execution of seasonal influenza vaccination, with relatively modest award sizes intended to catalyze planning, technical work, and early implementation steps.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This is a CDC discretionary grant opportunity titled CDC RFA IP13-1305. It is focused on helping selected foreign governments introduce seasonal influenza vaccination where it is not yet part of routine public health programming, or expand and strengthen existing seasonal influenza vaccination efforts.
What is the main goal of CDC RFA IP13-1305?
The goal is to support practical, policy-oriented work that leads to national-level policy decisions about seasonal influenza vaccine use and then helps countries move from those decisions into implementation of sustainable national influenza vaccination programs.
What pathway or sequence of work does the program support?
The program is designed to support the full pathway from evidence and deliberation to policy adoption and operational execution. This includes evaluating needs, building consensus, setting policy, planning operations, and carrying out early phases of influenza vaccine program rollout or expansion.
Who is the funding intended to benefit?
The funding is intended to support selected foreign governments in building government-owned seasonal influenza vaccination programs, rather than one-time campaigns.
Which agency issued the opportunity?
The opportunity was issued by the Centers for Disease Control and Prevention (CDC).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA IP13-1305.
What is the CFDA number associated with this grant?
The CFDA number listed is 93.283 (CDC Investigations and Technical Assistance).
What is the funding instrument?
The funding instrument is a grant.
What activity category does this opportunity fall under?
The opportunity falls under the health activity category.
How many awards did CDC anticipate making?
CDC anticipated making about five awards.
What was the estimated total funding amount?
The estimated total funding amount was $3,000,000.
What was the award ceiling?
The stated award ceiling was $250,000 per award.
What was the award floor?
The stated award floor was $0.
Was cost sharing or matching required?
No. The announcement stated there was no cost-sharing or matching requirement, meaning applicants were typically not required to contribute non-federal funds to be eligible or competitive under the announcement.
Who was eligible to apply?
Eligibility was limited to entities within selected foreign governments that are responsible for national vaccine policy and/or program implementation.
Does this opportunity appear broadly open to universities, NGOs, or private sector organizations?
Based on the eligibility description provided, it was not broadly open. Universities, NGOs, or private-sector organizations would not be eligible unless they were part of, or formally representing, the eligible government entities described in the full announcement.
Why is eligibility restricted to government entities?
The eligibility language indicates CDC intended to fund organizations that can directly influence national immunization policy decisions and can operationalize influenza vaccination within the public health system, rather than supporting external partners acting independently of government.
What kinds of outcomes does the announcement emphasize?
It emphasizes two connected outcomes: (1) government-led work that produces concrete national policy decisions on whether and how to introduce or expand seasonal influenza vaccination, and (2) practical implementation of national influenza vaccination programs once those policy choices are made.
What types of policy-related work are suggested by the description?
While specific allowable activities are not listed in the short description, the framing suggests support for planning and decision-making processes such as burden and risk assessments, economic or feasibility analyses, stakeholder coordination, drafting policy guidance, and strengthening advisory group processes.
What types of implementation work are suggested by the description?
Again, while not listed as an exhaustive set of allowable activities, the description suggests support for program planning, logistics, training, communication approaches, monitoring, and early rollout activities that help operationalize seasonal influenza vaccination as a sustainable national program.
Is the intent to fund a one-time influenza vaccination campaign?
No. The description emphasizes building a functioning, government-owned seasonal influenza vaccination program rather than a one-time campaign.
When was the opportunity posted?
The posting date (and creation date) was March 15, 2013.
What was the closing date for applications?
The original and current closing date was May 14, 2013.
Is this opportunity still open?
No. The opportunity is archived. The archive date was June 13, 2013.
Was there an active link to additional information in the listing?
The source notes that the additional information link provided in the listing was not active and instructed users to access the full announcement through the main posting interface.
How could applicants get help retrieving the full announcement?
CDC directed applicants to contact the Procurement and Grants Office (PGO), Technical Information Management Section (TIMS).
What contact information was provided for CDC PGO TIMS?
Phone: 770-488-2700. Email: pgotim@cdc.gov.
How should the award size be interpreted in practical terms?
The description suggests relatively modest award sizes intended to catalyze planning, technical work, and early implementation steps that help governments move from national policy decisions into early-stage implementation of seasonal influenza vaccination programs.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Reducing Emissions Using Methanotrophic Organisms for Transportation Energy (REMOTE)
Previous opportunity: Social Media Summit and Training
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA IP13 1305
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA IP13 1305) also looked into and applied for these:
| Funding Opportunity |
|---|
| Developing Research Capacity to Assess Health Effects Associated with Volcanic Emissions and other Environmental Exposures (R01) Apply for RFA EH 13 002 Funding Number: RFA EH 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention, Public Health Conference Support Apply for CDC RFA PS13 1305 Funding Number: CDC RFA PS13 1305 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| National Center for Environmental Health/Agency for Toxic Substances and Disease Registry Public Health Conference Support Program Apply for CDC RFA EH13 1306 Funding Number: CDC RFA EH13 1306 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| NIBIB Biomedical Technology Resource Centers (P41) Apply for PAR 13 144 Funding Number: PAR 13 144 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Animal Models and Related Biological Materials for Research (R21) Apply for PA 13 145 Funding Number: PA 13 145 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Promoting, Strengthening and Enhancing Disease Prevention by Collaboration with Targeted Stakeholders Apply for CDC RFA IP13 1303 Funding Number: CDC RFA IP13 1303 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $220,000 |
| USAID/Vietnam Request for Information (RFI) on Healthy Markets Activity Apply for SOL 486 13 00022 Funding Number: SOL 486 13 00022 Agency: Thailand USAID Bangkok Category: Health Funding Amount: $15,000,000 |
| Cooperative Centers on Human Immunology (U19) Apply for RFA AI 13 016 Funding Number: RFA AI 13 016 Agency: National Institutes of Health Category: Health Funding Amount: $1,750,000 |
| Limited Competition Dominantly Inherited Alzheimer Network (U19) Apply for PAR 13 147 Funding Number: PAR 13 147 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition Biomarkers for Older Controls at Risk for Dementia (BIOCARD) Study (U19) Apply for PAR 13 148 Funding Number: PAR 13 148 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Organizations for Chronic Disease Prevention Apply for CDC RFA DP10 10080401SUPP13 Funding Number: CDC RFA DP10 10080401SUPP13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $230,000 |
| NIAID Clinical Trial Implementation Grant (R01) Apply for PAR 13 149 Funding Number: PAR 13 149 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Clinical Trial Planning Grant (R34) Apply for PAR 13 150 Funding Number: PAR 13 150 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 13 151 Funding Number: PAR 13 151 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Aging Research Dissertation Awards to Increase Diversity (R36) Apply for PAR 13 152 Funding Number: PAR 13 152 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development and Characterization of Animal Models for Aging Research (R01) Apply for PA 13 155 Funding Number: PA 13 155 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development and Characterization of Animal Models for Aging Research (R21) Apply for PA 13 156 Funding Number: PA 13 156 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Using Evidence from Science and Community Practice to Develop Web and other Technology Based Tools for HIV Treatment Service Provider Organizations to Improve Linkage, Retention, and Re Engagement of HIV Positive Persons in Care Apply for CDC RFA PS13 1311 Funding Number: CDC RFA PS13 1311 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Drug Target Development and Validation for Antimicrobial Resistant Pathogens (R21/R33) Apply for RFA AI 13 019 Funding Number: RFA AI 13 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01) Apply for RFA AA 13 003 Funding Number: RFA AA 13 003 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA IP13 1305", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.